Service order form Preclinical

In vitro research for drug testing (up to 5 cell lines). Including studies of: Option A-VT

Cell viability

Cell death analysis

Cell cycle profiling

Study of biomarkers and mechanistic in in vitro experiments Option B-VT 1-3

mRNA-related experiments B-VT-1

Protein-related experiments B-VT-2

DNA-related experiments B-VT-3

In vitro 3D cultures (up to 5 cell lines) with: Option C-VT 1-2

Extracellular matrix C-VT-1

Tumor microenvironment cells C-VT-2

In vivo research for drug testing (each model) Option A-VV 1-4

Monotherapy (2 groups; up to 5 immunosuppressed mice per group). A-VV-1

Monotherapy (2 groups; up to 10 immunosuppressed mice per group). A-VV-2

Combinations of 2 drugs (4 groups; up to 5 immunosuppressed mice per group). A-VV-3

Combinations of 2 drugs (4 groups; up to 10 immunosuppressed mice per group). A-VV-4

In vivo research for drug testing (each model)Option B-VV 1-4

Monotherapy (2 groups; up to 5 immunocompetent* mice per group). B-VV-1

Monotherapy (2 groups; up to 10 immunocompetent* mice per group).  B-VV-2

Combinations of 2 drugs (4 groups; up to 5 immunosuppressed mice per group). B-VV-3

Combinations of 2 drugs (4 groups; up to 10 immunosuppressed mice per group). B-VV-4

Study of biomarkers in vivo experiments Option C-VV

mRNA expression C-VV-1

Protein expression C-VV-2

Other analysis (multiplexed, metabolomics, etc.) C-VV-3

Transcriptomic studies (HTG EdgeSeq) Option A-T 1-7

WTA miRNA Whole Transcriptome Assay Panel A-T-1

OBP Oncology Biomarker Panel A-T-2

Precision I/O Panel A-T-3

Immune Response Panel A-T-4

Mouse mRNA Tumor Response Panel A-T-5

Pan B-Cell Lymphoma Panel A-T-6

HTP Transcriptome Panel A-T-7

Basical Statistical analysis of transcriptomic studies

Option B-T

Other analysis (Personalized)

Option C-T